2026
Yuge Ji, Founder and CEO of Reflector Bio

Reflector Bio attends AIDDD 2026

The AI Drug Discovery & Development Summit in Boston brings together leaders advancing AI applications across drug discovery and development, from early research to clinical translation.

→

Reflector Bio attends the Oncology Venture, Innovation & Partnering Summit

The summit connects investors, biotech executives, and pharmaceutical leaders to discuss oncology innovation, investment, and strategic partnerships.

→

Reflector Bio attends ARDD 2026

The 13th Aging Research and Drug Discovery Meeting covers advances in aging biology, longevity therapeutics, and AI-driven drug discovery.

→

Reflector Bio attends Decoding Bio’s AI x Bio Summit

Held at the New York Stock Exchange, the summit brings together biotech founders, investors, scientists, and pharmaceutical leaders shaping the future of AI-driven biotechnology.

→

Yuge Ji, PhD speaks at the AI x Longevity Summit

Reflector Bio’s Founder and CEO spoke at Longevity Global’s New York City summit exploring the intersection of artificial intelligence and longevity science.

→

Reflector Bio attends the AWS Life Sciences Symposium 2026

The symposium focused on applications of agentic AI, machine learning, and cloud technologies across drug discovery, clinical development, and the life sciences.

→

Yuge Ji, PhD speaks at NGEN’s Lab-to-Startup Conference

Reflector Bio’s Founder and CEO joined a panel discussing the role of AI in scientific research at NGEN’s Science to Scale conference in New York City.

→

Reflector Bio selected for the 2026 NYCEDC Founder Fellowship

Selected as one of 60 startups in the 2026 cohort, Reflector Bio joins Company Ventures’ accelerator program, providing access to mentorship, investor networks, and business development support.

→

Yuge Ji, PhD speaks at NGEN’s Lab-to-Startup Conference

Yuge Ji, PhD, Founder and CEO of Reflector Bio, spoke on the “AI in Research” panel at the Lab-to-Startup Conference: Science to Scale, hosted by the NextGen Entrepreneurship Network (NGEN) in New York City.

Held at SOSV’s IndieBio, the one-day conference brought together more than 80 PhD, Master’s and research-driven founders from institutions including Harvard, MIT, Columbia, NYU, Princeton and the University of Pennsylvania. Its focus was turning scientific research into scalable, venture-backed companies.

The panel, which also featured Maria Luisa Pineda (Envisagenics), Joshua Ziel (Kynetyk AI) and Taiwo Togun (SeqHub Analytics), looked at the growing role of AI in accelerating research.

Read more →

Reflector Bio attends AIDDD 2026

Reflector Bio attends AIDDD 2026, the AI Drug Discovery & Development Summit, which focuses on applying AI across drug discovery and development.

Read more →

Reflector Bio attends the Oncology Venture, Innovation & Partnering Summit

Reflector Bio attends the Oncology Venture, Innovation & Partnering Summit, a partnering event that connects investors and business leaders to accelerate cancer innovation.

Read more →

Reflector Bio attends ARDD 2026

Reflector Bio attends ARDD 2026, the Aging Research and Drug Discovery meeting, where leaders in the aging and longevity field present the latest progress on the biology of aging and the search for interventions.

Read more →

Reflector Bio attends Decoding Bio’s AI x Bio Summit

Reflector Bio attends the Decoding Bio AI x Bio Summit, hosted by Decoding Bio, a community of experts exploring biotech and the latest developments in biology and AI.

Read more →

Reflector Bio attends the AWS Life Sciences Symposium 2026

Reflector Bio attends the AWS Life Sciences Symposium 2026, AWS’s life sciences event on what’s next for AI-driven discovery, development and patient impact.

Read more →

Reflector Bio attends BIO International Convention 2025

Reflector Bio attends BIO International Convention 2025, the Biotechnology Innovation Organization’s annual convention bringing together the global biotech ecosystem for programming, networking and partnering.

Read more →

Reflector Bio selected for the 2026 NYCEDC Founder Fellowship

Reflector Bio has been announced as part of the 2026 cohort of the NYCEDC Founder Fellowship, the New York City Economic Development Corporation's accelerator program for early-stage startups.

The fifth Founder Fellowship cohort brings together 60 early-stage New York City startups. Since launching in 2022, the program has supported nearly 400 founders across nearly 250 startups.

Read more →

Reflector Bio’s technology used in the Cancer Plasticity Atlas

Reflector Bio’s phenotypic prediction technology is being used in the Cancer Plasticity Atlas, a multi-institutional research effort to map cancer cell state transitions and predict response to therapy.

The Cancer Plasticity Atlas is a collaboration between Helmholtz Munich, the Wellcome Sanger Institute and Parse Biosciences to build a single-cell atlas of cancer plasticity and response to therapy. It is led by Fabian Theis, Reflector Bio’s scientific advisor, and Mathew Garnett of the Wellcome Sanger Institute.

Read more →

Yuge Ji, PhD speaks at the AI x Longevity Summit

Yuge Ji, PhD, Founder and CEO of Reflector Bio, spoke at the AI x Longevity Summit in New York City.

A flagship event of Longevity Global NYC, the summit brings together researchers, clinicians, founders and engineers to explore how AI is accelerating longevity science.

Read more →